Stratec SE (SBS.DE)
EUR 28.25
(-1.91%)
EUR 28.25
(-1.91%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 22.88 Million EUR | -40.63% |
| 2022 | 41.78 Million EUR | -17.72% |
| 2021 | 50.78 Million EUR | 56.33% |
| 2020 | 32.48 Million EUR | 69.99% |
| 2019 | 19.1 Million EUR | 22.08% |
| 2018 | 15.65 Million EUR | -45.72% |
| 2017 | 28.84 Million EUR | 19.15% |
| 2016 | 24.2 Million EUR | -9.94% |
| 2015 | 26.87 Million EUR | 11.74% |
| 2014 | 24.05 Million EUR | 23.39% |
| 2013 | 19.49 Million EUR | 10.64% |
| 2012 | 17.61 Million EUR | -19.35% |
| 2011 | 21.84 Million EUR | 24.05% |
| 2010 | 17.6 Million EUR | 148.72% |
| 2009 | 7.07 Million EUR | -76.61% |
| 2008 | 30.26 Million EUR | -3.75% |
| 2007 | 31.44 Million EUR | -17.97% |
| 2006 | 38.33 Million EUR | 150.51% |
| 2005 | 15.3 Million EUR | 38.67% |
| 2004 | 11.03 Million EUR | -56.17% |
| 2003 | 25.17 Million EUR | 30.55% |
| 2002 | 19.28 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 3.46 Million EUR | -37.99% |
| 2024 Q2 | 5.58 Million EUR | 394.51% |
| 2024 Q1 | 1.13 Million EUR | -88.65% |
| 2023 FY | 24.8 Million EUR | -40.63% |
| 2023 Q1 | 2.92 Million EUR | -47.28% |
| 2023 Q2 | 1.84 Million EUR | -36.8% |
| 2023 Q3 | 8.52 Million EUR | 361.04% |
| 2023 Q4 | 9.95 Million EUR | 16.81% |
| 2022 Q1 | 14.1 Million EUR | 305.08% |
| 2022 Q2 | 5.23 Million EUR | -62.89% |
| 2022 FY | 41.78 Million EUR | -17.72% |
| 2022 Q3 | 16.1 Million EUR | 207.78% |
| 2022 Q4 | 5.54 Million EUR | -65.57% |
| 2021 FY | 50.78 Million EUR | 56.33% |
| 2021 Q3 | 13.23 Million EUR | -19.16% |
| 2021 Q4 | 3.48 Million EUR | -73.7% |
| 2021 Q1 | 14.12 Million EUR | 17.67% |
| 2021 Q2 | 16.37 Million EUR | 15.88% |
| 2020 FY | 32.48 Million EUR | 69.99% |
| 2020 Q3 | 7.71 Million EUR | -11.76% |
| 2020 Q2 | 8.74 Million EUR | 56.2% |
| 2020 Q1 | 5.59 Million EUR | -39.03% |
| 2020 Q4 | 12 Million EUR | 55.66% |
| 2019 Q1 | 2.07 Million EUR | -73.47% |
| 2019 FY | 19.1 Million EUR | 22.08% |
| 2019 Q2 | 4.82 Million EUR | 132.03% |
| 2019 Q3 | 4.17 Million EUR | -13.5% |
| 2019 Q4 | 9.17 Million EUR | 119.96% |
| 2018 Q2 | 2.26 Million EUR | 56.05% |
| 2018 Q3 | 4.35 Million EUR | 91.76% |
| 2018 Q4 | 7.83 Million EUR | 80.12% |
| 2018 Q1 | 1.45 Million EUR | -87.15% |
| 2018 FY | 15.65 Million EUR | -45.72% |
| 2017 Q2 | 3.96 Million EUR | -15.37% |
| 2017 FY | 28.84 Million EUR | 19.15% |
| 2017 Q4 | 11.31 Million EUR | 27.44% |
| 2017 Q3 | 8.87 Million EUR | 124.05% |
| 2017 Q1 | 4.68 Million EUR | -62.5% |
| 2016 Q3 | 1.76 Million EUR | -67.47% |
| 2016 Q1 | 4.52 Million EUR | -40.72% |
| 2016 Q2 | 5.42 Million EUR | 19.72% |
| 2016 FY | 24.2 Million EUR | -9.94% |
| 2016 Q4 | 12.48 Million EUR | 607.99% |
| 2015 Q2 | 6.14 Million EUR | 5.24% |
| 2015 Q1 | 5.84 Million EUR | -16.69% |
| 2015 Q3 | 7.24 Million EUR | 17.95% |
| 2015 Q4 | 7.64 Million EUR | 5.39% |
| 2015 FY | 26.87 Million EUR | 11.74% |
| 2014 Q1 | 4.36 Million EUR | -28.77% |
| 2014 Q2 | 5.9 Million EUR | 35.21% |
| 2014 Q4 | 7.01 Million EUR | 3.58% |
| 2014 Q3 | 6.76 Million EUR | 14.6% |
| 2014 FY | 24.05 Million EUR | 23.39% |
| 2013 FY | 19.49 Million EUR | 10.64% |
| 2013 Q2 | 3.94 Million EUR | -10.58% |
| 2013 Q1 | 4.4 Million EUR | 3.4% |
| 2013 Q4 | 6.13 Million EUR | 22.27% |
| 2013 Q3 | 5.01 Million EUR | 27.28% |
| 2012 Q2 | 5.07 Million EUR | 16.69% |
| 2012 Q4 | 4.26 Million EUR | 8.34% |
| 2012 FY | 17.61 Million EUR | -19.35% |
| 2012 Q1 | 4.34 Million EUR | -35.85% |
| 2012 Q3 | 3.93 Million EUR | -22.5% |
| 2011 Q4 | 6.77 Million EUR | 12.8% |
| 2011 Q1 | 3.98 Million EUR | -68.83% |
| 2011 Q3 | 6.01 Million EUR | 17.11% |
| 2011 FY | 21.84 Million EUR | 24.05% |
| 2011 Q2 | 5.13 Million EUR | 28.88% |
| 2010 Q1 | 3.74 Million EUR | 5.15% |
| 2010 FY | 17.6 Million EUR | 148.72% |
| 2010 Q2 | 4.22 Million EUR | 12.8% |
| 2010 Q3 | 4.83 Million EUR | 14.54% |
| 2010 Q4 | 12.77 Million EUR | 164.13% |
| 2009 Q2 | 3.52 Million EUR | 28.74% |
| 2009 Q3 | -2.71 Million EUR | -176.91% |
| 2009 FY | 7.07 Million EUR | -76.61% |
| 2009 Q1 | 2.73 Million EUR | 0.0% |
| 2009 Q4 | 3.55 Million EUR | 231.31% |
| 2008 FY | 30.26 Million EUR | -3.75% |
| 2007 FY | 31.44 Million EUR | -17.97% |
| 2006 FY | 38.33 Million EUR | 150.51% |
| 2005 FY | 15.3 Million EUR | 38.67% |
| 2004 FY | 11.03 Million EUR | -56.17% |
| 2003 FY | 25.17 Million EUR | 30.55% |
| 2002 FY | 19.28 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| aap Implantate AG | -5.16 Million EUR | 542.794% |
| Drägerwerk AG & Co. KGaA | 171.18 Million EUR | 86.629% |
| Drägerwerk AG & Co. KGaA | 171.18 Million EUR | 86.629% |
| elexxion AG | -417.66 Thousand EUR | 5580.029% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 46.99 Million EUR | 51.298% |
| Geratherm Medical AG | 2.21 Million EUR | -931.353% |
| Koninklijke Philips N.V. | -115 Million EUR | 119.903% |
| Siemens Healthineers AG | 2.86 Billion EUR | 99.202% |